Obsidian Therapeutics Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb Pharmaceutical Investing
Mindset Pharma Announces Poster Presentations at Two Upcoming Scientific Conferences Biotech Investing
New Zeposia Data Highlight COVID-19 Outcomes and Preservation of Long-Term Cognitive Function from Separate Analyses in Patients with Relapsing Forms of Multiple Sclerosis Pharmaceutical Investing
The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of Physicians to be Trained in the $114 Million Program Pharmaceutical Investing
Ginkgo Bioworks and the Ministry of Investment of Saudi Arabia Announce Plans to Develop Biosecurity and Biotechnology Capabilities for Global Public Health Company News
Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases Pharmaceutical Investing
AbbVie to Present Data from Extensive Portfolio at American College of Gastroenterology Annual Scientific Meeting Pharmaceutical Investing
New Data Presented at the American College of Gastroenterology Annual Scientific Meeting Demonstrate Continuous Zeposia Treatment Prevents Disease Relapse Over One Year in 86.1% of Patients Who Respond at the End of the Induction Period Pharmaceutical Investing
